Note sull'episodio
In this episode, we dissect Nvidia's strategic move, investing a substantial $50 million in the AI drug discovery firm Recursion. Join me as we delve into the implications of this financial infusion and its potential impact on the intersection of AI and pharmaceuticals.
-
Invest in AI Box: https://Republic.com/ai-box
-
Get on the AI Box Waitlist: https://AIBox.ai/